In patients with drug-resistant tuberculosis who receive treatment with new and repurposed drugs, indicators of advanced disease and delayed conversion were associated with an increased risk of reversion. These factors may be targets for close monitoring.
- Sooyeon Kho
- Kwonjune J. Seung
- Molly Franke
